LYVE1 Protein

Produktnummer ABIN4888439

Dieses Recombinant LYVE1-Protein wird in Insect cells (Sf9) produziert.

Kurzübersicht für LYVE1 Protein (ABIN4888439)

Target: LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))

Protein-Typ: Recombinant

Spezies: Human

Quelle: Insect cells (Sf9)

Reinheit: > 95 % pure

Produktdetails

Produktmerkmale: Purified recombinant Human LYVE1 protein
Expression System: Sf-9 insect cells

Endotoxin-Niveau: < 0.1 ng per µg of VEGF-C

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute in sterile water to a concentration > 0.05 mg/mL.

Buffer: Supplied as a lyophilized powder with no preservative.

Konservierungsmittel: Without preservative

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: -20 °C/-80 °C

Antigendetails

Target: LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))

Andere Bezeichnung: LYVE1

Hintergrund: LYVE-1 has been identified as a major receptor for HA (extracellular matrix glycosaminoglycan hyaluronan) on the lymph vessel wall. The deduced amino acid sequence of LYVE-1 predicts a 322-residue type I integral membrane polypeptide 41 % similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module the prototypic HA binding domain of the Link protein superfamily. Like CD44, the LYVE-1 molecule binds both soluble and immobilized HA.
Alternative Names: Lymphatic Vessel protein, LYVE 1 protein, LYVE 1, LYVE-1 protein, LYVE1, LYVE-1 protein, Lymphatic Endothelial Cell protein, LYVE-1

Molekulargewicht: 35-45 kDa

Pathways: Glycosaminoglycan Metabolic Process